Main Uses of L-Thyroxin Henning 150

L-Thyroxin Henning 150 is a thyroid hormone preparation containing levothyroxine sodium as its active ingredient. This synthetic hormone is identical in effect to the naturally occurring thyroxine produced by the thyroid gland. It is primarily used to restore hormonal balance in patients who do not produce sufficient amounts of thyroid hormone naturally.

Treatment of Hypothyroidism

The primary application of this medication is for the replacement of thyroid hormones in various forms of hypothyroidism (underactive thyroid). This includes:

• Primary Hypothyroidism: Where the thyroid gland itself is unable to produce enough hormone.
• Secondary Hypothyroidism: Where the pituitary gland does not signal the thyroid correctly.
• Post-Surgical Replacement: To replace thyroid function after the partial or total surgical removal of the thyroid gland.
• Post-Radiation Therapy: Following treatment with radioactive iodine or external radiation that has reduced thyroid function.

Management of Goiter

L-Thyroxin Henning 150 is used to treat benign (non-cancerous) goiters, which are enlargements of the thyroid gland. In these cases, the medication helps to:

• Reduce the size of an enlarged thyroid gland.
• Prevent the recurrence of a goiter after surgical removal, especially when thyroid function is normal but the gland requires suppression to prevent regrowth.

Use in Oncology

In patients with thyroid carcinoma (thyroid cancer), this medication is used following surgery. Its purpose is to suppress the production of Thyroid Stimulating Hormone (TSH) from the pituitary gland, which helps to inhibit the growth of any remaining thyroid cancer cells and provides necessary hormone replacement.

Benefits and Physiological Effects

By supplementing the body's natural hormone levels, L-Thyroxin Henning 150 supports essential metabolic processes throughout the body. The restoration of normal thyroid hormone levels provides several physiological benefits:

• Metabolic Regulation: It helps maintain the basal metabolic rate, influencing how the body uses energy.
• Organ Function: Supports the normal functioning of the heart, brain, and muscles.
• Temperature Regulation: Assists in maintaining stable body temperature.
• Symptom Relief: Alleviates the common symptoms associated with an underactive thyroid, such as extreme fatigue, sensitivity to cold, weight gain, and mental slowness.

Regulatory References

1. NIH MedlinePlus overview

L-Thyroxin Henning 150, which contains the active ingredient levothyroxine, is not suitable for all individuals and is officially contraindicated in several specific populations.

Contraindicated Populations

Use is strictly prohibited for patients with:

• Hypersensitivity (allergy) to levothyroxine or any inactive ingredient.
• Untreated thyrotoxicosis (overactive thyroid) of any cause.
• Acute myocardial infarction (recent heart attack), acute myocarditis, or acute pancarditis (inflammation of the heart).
• Uncorrected adrenal insufficiency (adrenal gland disorder), as thyroid hormone may precipitate a serious acute crisis.
• Pregnancy, if used as part of combination therapy with anti-thyroid agents for hyperthyroidism.

Populations Requiring Special Consideration

Treatment requires extreme caution and often a lower starting dose in certain groups:

• Elderly patients and individuals with underlying cardiovascular disease (e.g., coronary artery disease or high blood pressure) are at increased risk of cardiac complications and must start treatment very gradually.
• Patients with adrenal insufficiency must initiate glucocorticoid (corticosteroid) therapy before starting L-Thyroxin Henning to prevent an acute adrenal crisis.

Other Limitations

This medication is explicitly not recommended for the treatment of obesity or for weight loss in individuals with normal thyroid function, due to the risk of serious toxicity.

Interactions with other medicines and products

Official regulatory information describes interactions that may alter the effectiveness of this product or the co-administered medicine, requiring careful attention to drug combinations and administration timing.

Impact on Co-administered Medications

Product Category
Anticoagulants (Coumarin derivatives)	Levothyroxine can enhance the effect of these blood thinners, necessitating regular monitoring of blood clotting and potential dose reduction of the anticoagulant.
Antidiabetics (Insulin, oral agents)	Levothyroxine may reduce the effect of these medicines, requiring frequent blood sugar monitoring and potential adjustment of the antidiabetic dose.
Tricyclic Antidepressants/Sympathomimetics	Co-administration may accelerate the effect of tricyclics and increase the effect of sympathomimetics; combination with sympathomimetic amines for weight reduction is advised against by regulatory bodies due to risk of serious effects.

Impact on Levothyroxine Levels

Absorption of this medicine may be reduced when co-administered with certain products, leading to lower levothyroxine levels. These products include acid-binding agents (e.g., aluminum-containing antacids, sucralfate), calcium and iron salts, and bile acid sequestrants (e.g., colestyramine, colesevelam). A minimum separation interval between administrations, typically two to five hours, is officially mandated to manage this effect. Additionally, other agents such as proton pump inhibitors (PPIs) and anticonvulsants may necessitate monitoring due to their potential to alter hormone absorption or metabolism.

How L-Thyroxin Henning 150 Works

1. Prohormone Activation and Nuclear Receptor Control

The active ingredient, Levothyroxine (L-T4), functions as a synthetic prohormone that is transported into cells and enzymatically converted by deiodinases into the active hormone, Triiodothyronine (T3). This T3 then acts as a nuclear receptor agonist, binding to intracellular receptors to regulate gene expression. This genomic signaling initiates the synthesis of proteins that dictate the body's rate of energy expenditure and growth, and contributes to the modulation of fundamental metabolic processes.

2. Global Regulation of Basal Metabolism

This mechanism targets key pathways that govern cellular energy use and thermogenesis. The resulting protein synthesis leads to the widespread upregulation of metabolic enzymes (such as Na^+/ K^+-ATPase) across all organ systems. This action accelerates the consumption of glucose and fats and increases oxygen demand, resulting in the adjustment of energy substrate utilization and thermal processes.

3. Modulation of Cardiac Function and Hormonal Feedback

Beyond cellular energy, the mechanism directly influences the cardiovascular system by altering the expression of contractile proteins in the heart muscle. It also acts centrally to control the Hypothalamic-Pituitary-Thyroid (HPT) axis by exerting negative feedback on the pituitary gland, thereby regulating the release of TSH. This dual-systemic control facilitates the physiological adjustment of heart function and modulates hormonal balance.

L-Thyroxin Henning 150 (levothyroxine sodium) is an oral tablet used for chronic hormone replacement and is administered according to established procedural guidelines.

Administration Scope

Instruction	Official Regulatory Guideline
Route of Administration	The primary route is Oral for long-term therapy. Intravenous administration is reserved for acute conditions.
Dosing Schedule	Dosing is highly individualized. The average full replacement dose for healthy adults is approximately 1.6 mcg per kg per day. Initial doses in adults often start between 25 and 50 mcg daily and are adjusted gradually.
Timing in Relation to Meals	Take the tablet once daily on an empty stomach, ideally one-half to one hour before breakfast.
Preparation Requirements	Tablets should be swallowed whole. For infants, tablets may be crushed and suspended in a small amount of water (5 to 10 mL) for immediate administration; the suspension must not be stored.
Age-Group Rules	Older adults and those with underlying cardiac disease must start with a lower initial dose (12.5 to 25 mcg/day) and undergo slower dose increases (every 6 to 8 weeks).
Missed-Dose Rules	If a dose is missed, take it as soon as it is remembered. If it is almost time for the next scheduled dose, the missed dose should be skipped; do not double the dose to make up for a missed one.

Connection to the Overall Use Protocol

Standard instructions define the use protocol to maximize predictable absorption and ensure stable hormone delivery. This includes the mandatory once daily frequency and the requirement for administration on an empty stomach, separated by at least 4 hours from substances like calcium or iron, to maintain consistent blood levels. Dosage titration is a gradual process guided by periodic TSH level monitoring, typically occurring every 4 to 6 weeks, which is necessary to achieve the final, sustained maintenance dose.

Evidence for Replacement Therapy in Primary Hypothyroidism

Research exploring the use of levothyroxine sodium for deficient thyroid hormone supply, known as primary hypothyroidism, comprises a vast amount of evidence evaluated in large-scale systematic reviews and long-term observational cohort studies. These studies examined a broad population, including adults, children, and pregnant individuals. Data show patterns related to the achievement of TSH and T4 levels within the target range across the observed populations. Research summaries describe that the use of levothyroxine may be required for lifelong hormone replacement. Observational data show patterns related to how symptoms evolved in the observed populations, such as chronic fatigue, in individuals whose biomarker levels reached the target range during the study period. What remains uncertain is the challenge in ensuring optimal biomarker levels in the overall population, with real-world data showing patterns related to under- or over-treatment in some individuals.

---

Evidence for Thyrotropin Suppressive Therapy and Subclinical Use

Research has also explored the use of levothyroxine in doses higher than standard replacement for TSH suppression following treatments for conditions like certain thyroid cancers. Studies monitored the incidence of goitre recurrence and evaluated outcomes such as recurrence-free survival during periods where TSH suppression was achieved. Evidence suggests that findings were mixed regarding changes in goitre size.

For subclinical hypothyroidism (mildly elevated TSH), Randomized Controlled Trials (RCTs) monitored changes in TSH levels and standardized symptom relief scores. Findings were inconsistent across trials that measured non-specific patient-reported outcomes (such as Quality of Life) in individuals with only mildly elevated TSH. Evidence is limited and heterogeneous regarding changes in physical discomfort for these patients.

---

Research Gaps and Special Populations

Long-term data highlights the challenge in ensuring optimal biomarker levels across the full lifespan. While treatment is lifelong, studies monitored changes in the dose required over time. Research has explored the therapy in children and pregnant individuals, and studies monitored outcomes related to physical and neurological markers in children. Data for certain groups remain insufficient in the research landscape. The evidence highlights that the findings reflect the specific conditions under which they were conducted, and findings describe group patterns, not personal outcomes.

Key Studies & References

1. Levothyroxine Sodium (Synthetic T4): A Review of the Evidence for Dosing and Clinical Efficacy
2. Thyroid Hormone Replacement in Pregnancy: A Clinical Review of Current Guidelines

Common questions about L-Thyroxin Henning 150 (FAQ)

---

Q: What is the active ingredient in L-Thyroxin Henning 150?

The active ingredient in L-Thyroxin Henning 150 is Levothyroxine sodium. According to regulatory documents, this substance is a synthetic version of the natural thyroid hormone thyroxine, which plays a key role in the body's metabolism.

---

Q: What kind of substance is levothyroxine?

Levothyroxine is classified as a thyroid hormone preparation. Official product information indicates that it is a synthetic hormone intended to replace or supplement the natural thyroxine hormone (T4) that the body may not be producing sufficiently.

---

Q: What is the primary condition L-Thyroxin Henning 150 is used to treat?

L-Thyroxin Henning 150 is primarily used for the treatment of hypothyroidism (underactive thyroid). Regulatory sources state that its purpose is to help restore deficient thyroid hormone levels in patients whose thyroid gland is underperforming.

---

Q: Does L-Thyroxin Henning 150 require a prescription?

Yes, L-Thyroxin Henning 150 is classified as a prescription-only medicine. This means that according to official regulatory rules, it must be dispensed by a pharmacist only upon presentation of a valid prescription from a qualified healthcare professional.

---

Q: What is the recommended frequency for taking L-Thyroxin Henning 150?

According to the official product information, L-Thyroxin Henning 150 is generally taken once daily. Regulatory documents indicate that this frequency is typically advised, and specific instructions regarding the time of day and relationship to meals are provided in the product leaflet.

Storage and Disposal Requirements for L-Thyroxin Henning 150

The storage of L-Thyroxin Henning 150 (Levothyroxine Sodium) must strictly follow regulatory standards to ensure tablet stability. The medicine must be stored below 25 C and kept in its original package to provide protection from light and moisture. This medication must always be stored out of the sight and reach of children.

---

Handling and Disposal

The full 24-month shelf life is dependent on maintaining the required storage conditions. Any unused or expired L-Thyroxin Henning 150 must be disposed of in accordance with local regulatory requirements. The product should not be discarded via household waste or wastewater to protect the environment.